Elaeocarpus ganitrus (Elaeocarpaceae) Rudraksha, Blue Marble Tree, Utrasum Bead Tree
Elaeocarpus ganitrus, known as Rudraksha, is a large evergreen tree revered across the Indian subcontinent for the textured, compartmentalized beads derived from its stony endocarp. These beads hold profound spiritual significance in Hinduism, worn as prayer malas and believed to confer calm, focus, and protection upon the wearer. Beyond devotion, Rudraksha occupies a respected place in Ayurveda, where the seeds, bark, and leaves have been employed for centuries to manage hypertension, anxiety, epilepsy, diabetes, and a range of inflammatory conditions. Modern pharmacological research increasingly validates these traditional applications, demonstrating antihypertensive, antidiabetic, gastroprotective, antimicrobial, and cardioprotective activities. Recent investigations have explored novel dimensions, including wearable bio-electromagnetic therapeutic systems derived from pulverized seeds for cardiovascular support and in silico evidence of phytochemical interaction with cancer-related protein targets, while long-standing safety studies confirm an exceptionally wide margin of tolerance.
---
1. Taxonomic Insights
Species: Elaeocarpus ganitrus Roxb. ex G. Don
Family: Elaeocarpaceae (Elaeocarpus Family)
Genus: Elaeocarpus
Basionym: Elaeocarpus ganitrus Roxb.
Synonyms: Elaeocarpus sphaericus (Gaertn.) K. Schum., Elaeocarpus angustifolius Blume
---
Botanical Description
Elaeocarpus ganitrus is a large, evergreen broad-leaved tree that can reach heights of 20 to 30 metres under favourable conditions. The tree possesses a dense, rounded canopy and a straight, cylindrical bole with greyish-brown bark that becomes fissured with age. It is a long-lived species, capable of surviving for decades and producing fruit annually once mature.
Key Identification Features:
The leaves are simple, alternate, and clustered at the ends of branchlets. They are oblong to lanceolate, measuring 10 to 18 centimetres in length and 3 to 6 centimetres in width, with a serrated or crenate margin and an acuminate apex. The upper surface is dark green and glossy, while the lower surface is paler. The leaves turn red before falling, adding ornamental value to the tree.
The flowers are small, white to pale cream, and borne in axillary racemes. They are bell-shaped, about 1 to 1.5 centimetres across, with fringed petals that give them a delicate, feathery appearance. Flowering occurs from April to June in its native range.
The fruit is an ovoid to globose drupe, 2 to 3 centimetres in diameter, initially green and turning blue to bluish-purple when ripe. The fruit contains a single, large, deeply sculptured seed or endocarp, which is the source of the Rudraksha bead. The endocarp is hard and stony, with a surface divided into segments or facets called mukhas (faces), ranging from one to thirty-eight in number. The five-faced (panchmukhi) bead is the most commonly found and most widely used.
Distribution: The tree is native to the Indian subcontinent, with natural populations in the Himalayan foothills (Assam, West Bengal, Bihar, Sikkim), central India (Madhya Pradesh, Maharashtra), and parts of Southeast Asia (Nepal, Myanmar, Thailand, Indonesia, and the Philippines). It is also found in northern Australia and the Pacific Islands. It grows at elevations from sea level to approximately 2,000 metres in tropical and subtropical climates.
Conservation Status: The species is not currently listed as threatened by the IUCN. However, overharvesting for the Rudraksha bead trade has raised concerns in some regions. Cultivation is being promoted to meet demand sustainably.
---
Etymology
The generic name Elaeocarpus is derived from the Greek words elaia, meaning olive, and karpos, meaning fruit, referring to the olive-like appearance of the fruit. The specific epithet ganitrus is of uncertain origin but may relate to the Sanskrit term for the tree or its beads. The common name Rudraksha is derived from Sanskrit: Rudra, a Vedic deity associated with Shiva, and aksha, meaning eye or teardrop. According to Hindu mythology, Rudraksha beads originated from the tears of Lord Shiva, and the name reflects the belief that these beads possess divine protective and healing properties.
---
2. Common Names
Scientific Name: Elaeocarpus ganitrus | English: Rudraksha, Blue Marble Tree, Utrasum Bead Tree, Indian Olive | Sanskrit: Rudraksha, Shivaphal, Rudraksha | Hindi: Rudraksha | Bengali: Rudraksha, Jalpai | Tamil: Rudraksham | Telugu: Rudrakshamu | Kannada: Rudrakshi | Malayalam: Rudraksham | Marathi: Rudraksha | Gujarati: Rudraksha | Oriya: Rudraksha | Assamese: Rudraksha | Nepali: Rudraksha | Thai: Mahae | Indonesian: Jenitri | Filipino: Utrasum | French: Arbre aux perles | Spanish: Árbol de las cuentas
---
3. Related Herbs from the Elaeocarpaceae Family
Elaeocarpus ganitrus belongs to the Elaeocarpaceae family, a tropical and subtropical family of approximately 12 genera and 600 species, best known for the distinctive blue fruits of many species.
Elaeocarpus sylvestris: A closely related species widely distributed in East Asia, used traditionally for dysentery and inflammation. Its leaves contain similar alkaloids and flavonoids, and it demonstrates antimicrobial and anti-inflammatory activities.
Elaeocarpus angustifolius: Native to Australia and the Pacific, known as Blue Quandong or Blue Marble Tree. The fruit is edible but astringent, and the seeds are used traditionally for food and medicine.
Elaeocarpus serratus: Found in the Western Ghats and Sri Lanka, known as Ceylon Olive or Veralu. The fruit is edible and used traditionally for diarrhoea, dysentery, and rheumatism.
Elaeocarpus tuberculatus: A South Indian species with similar bead-producing fruits, used traditionally for similar medicinal purposes.
The Elaeocarpaceae family is characterised by the presence of alkaloids, flavonoids, phenolic compounds, and cucurbitacins. In Elaeocarpus ganitrus, the alkaloids (including rudrakine) and flavonoids are considered the primary bioactive constituents, contributing to its broad pharmacological profile.
---
4. Medicinal Uses: Summary of Primary and Secondary Actions
Primary Actions:
Antihypertensive: Aqueous extract of seeds demonstrates significant blood pressure reduction in hypertensive animal models. One study demonstrated that 15 milligrams per kilogram of a copper-extracted preparation reduced blood pressure by 30.20 millimetres of mercury in hypertensive rats, with similar effects observed at 30 milligrams per kilogram of a glass-extracted preparation . The aqueous extract has also shown efficacy in renal artery-occluded hypertensive rats, significantly decreasing elevated blood pressure after six weeks of treatment .
Antidiabetic: Aqueous seed extract demonstrates significant hypoglycemic activity in normal rats and antihyperglycemic effects in streptozotocin-induced diabetic rats. In normoglycemic rats, the extract at 1,000 milligrams per kilogram reduced blood glucose by 28.77 percent at two hours. In diabetic rats over 30 days, the extract at 1,000 milligrams per kilogram reduced fasting blood glucose by 49.39 percent, comparable to metformin's 53.32 percent reduction. The extract also modulated lipid profiles in a dose-dependent manner .
Gastroprotective: Leaf extracts demonstrate significant gastroprotective activity in various ulcer models. The methanolic extract, containing lupeol and ursolic acid, reduced ulcer indices in a dose-dependent manner and showed in vitro anticholinergic and antihistaminic activity. Molecular docking studies confirmed interaction with muscarinic M3 receptors .
Antimicrobial: Ethanolic extracts demonstrate significant antibacterial activity against multidrug-resistant Escherichia coli and Staphylococcus aureus isolated from bovine mastitis. The extract yields were 9.56 percent, containing alkaloids, tannins, phenols, flavonoids, terpenoids, phytosterols, and steroids . Seed extracts also demonstrate broad-spectrum antifungal activity against Aspergillus niger, Candida albicans, and other fungal strains .
Cardioprotective: Hydroalcoholic extract attenuates right ventricular dysfunction in monocrotaline-induced pulmonary hypertension in rats. Treatment downregulated fibrotic and inflammatory markers including alpha-smooth muscle actin, galectin-3, C-reactive protein, troponin I, connective tissue growth factor, and atrial natriuretic peptide. Histological studies showed restoration of cardiac morphology, and UPLC-QTOF/MS analysis identified 36 chemical constituents .
Antioxidant: Leaf extracts exhibit significant antioxidant activity in various in vitro methods, including total antioxidant activity, reducing power potential, metal chelating activity, and ABTS scavenging. A positive correlation exists between total phenolic content and antioxidant capacity .
Secondary Actions:
Antidepressant and Anxiolytic: Traditional use for anxiety, depression, and stress is supported by the plant's reputation as a natural tranquilizer. The hydroalcoholic extract demonstrates downregulation of neurohormonal and oxidative stress markers .
Anticonvulsant: Traditional use for epilepsy and convulsions is documented, though specific mechanistic studies are limited .
Anti-inflammatory: Various extracts demonstrate anti-inflammatory activity in animal models, supporting traditional use for inflammatory conditions .
Immunostimulatory: The alkaloidal fraction of seeds stimulates immune mediators from peritoneal exudate cells and promotes proliferation of immune cells in in vitro and in vivo models .
Nephroprotective: Ethanolic extract of seeds demonstrates protective effects against gentamicin-induced nephrotoxicity in rats .
Antiasthmatic: Fruit extracts exhibit mast-cell stabilizing activity, substantiating traditional use for bronchial asthma .
Analgesic: Traditional use for neuralgia and migraine is documented, with preliminary evidence of analgesic activity .
Anticancer: In silico studies suggest that phytochemicals from E. ganitrus extract interact with STAT3, a protein involved in cancer progression, indicating potential anticancer properties warranting further investigation .
---
Medicinal Parts
The seeds (endocarp), leaves, and bark are the primary medicinal parts, with traditional and modern uses varying by preparation and application.
Seeds and Endocarp: The stony endocarp, which forms the Rudraksha bead, is the most valued medicinal and spiritual part. The seeds are used in aqueous and ethanolic extracts for hypertension, diabetes, and as a general tonic. The bead itself is worn for its purported bio-electromagnetic and spiritual benefits.
Leaves: Used for their antioxidant, antimicrobial, gastroprotective, and antidiabetic properties. Leaf extracts contain alkaloids, flavonoids, and phenolic compounds, and demonstrate significant antioxidant activity .
Bark: Used traditionally as an astringent and for treating diarrhoea and dysentery. The bark contains similar phytochemicals to the leaves and seeds.
Fruit Pulp: The pulp of ripe fruits is edible and is used traditionally to stimulate appetite and treat mental illness. The seed kernel is applied externally for burns, smallpox eruptions, measles, and fever .
---
5. Phytochemistry
5.1 Alkaloids
The plant contains several alkaloids that contribute to its pharmacological activity, particularly its effects on the central nervous system and cardiovascular system.
Rudrakine: An alkaloid isolated from the leaves of Elaeocarpus ganitrus, representing one of the characteristic alkaloids of the species .
Elaeocarpine and Isoelaeocarpine: Indolizidine alkaloids present in various Elaeocarpus species, with documented effects on neurotransmitter systems.
Other Alkaloids: The seeds contain alkaloids that demonstrate immunostimulatory activity, stimulating immune mediators from peritoneal exudate cells and promoting immune cell proliferation .
5.2 Flavonoids and Phenolic Compounds
The plant is rich in flavonoids and phenolic compounds, which contribute significantly to its antioxidant and anti-inflammatory properties.
Total Phenolic Content: Leaf extracts show a positive correlation between total phenolic content and antioxidant capacity, indicating that phenolics are major contributors to the plant's antioxidant activity .
Total Flavonoid Content: Flavonoids are present in significant quantities and correlate with antioxidant activity. The anxiolytic activity of related species has been attributed to high flavonoid content .
Specific Flavonoids: Various flavonoids have been identified, contributing to the plant's anti-inflammatory, antioxidant, and antimicrobial activities.
5.3 Tannins, Terpenoids, and Steroids
The plant contains a diverse array of secondary metabolites that contribute to its pharmacological profile.
Tannins: Present in significant quantities, contributing to the plant's astringent and antimicrobial properties.
Terpenoids: Present in ethanolic extracts, contributing to anti-inflammatory and antimicrobial activities.
Phytosterols and Steroids: Present in the endocarp and seeds, including compounds that contribute to the plant's anti-inflammatory and immunomodulatory effects.
Lupeol and Ursolic Acid: Identified in leaf extracts through HPTLC studies. These triterpenoids are known for their gastroprotective, anti-inflammatory, and anticancer activities .
5.4 Fatty Acids and Other Compounds
The seeds contain fatty acids that contribute to their nutritional and medicinal value. Carbohydrates, proteins, and cardiac glycosides have also been reported in the plant .
---
6. Mechanisms of Action
6.1 Antihypertensive Activity: Renin-Angiotensin Modulation and Copper Interaction
The antihypertensive effect of Elaeocarpus ganitrus seeds is mediated through multiple mechanisms. The aqueous extract induces a hypotensive effect in stress-induced hypertension, possibly due to its effect on the renin-angiotensin-aldosterone system . Studies in renal artery-occluded hypertensive rats demonstrated significant blood pressure reduction after six weeks of treatment, suggesting sustained modulation of the renin-angiotensin system . An intriguing finding is that copper ions may additively enhance the antihypertensive effect: extract prepared in a copper vessel produced similar blood pressure reduction at half the dose compared to extract prepared in a glass vessel (15 milligrams per kilogram versus 30 milligrams per kilogram), suggesting that copper ions leached into the extract may potentiate its activity .
6.2 Antidiabetic Activity: Hypoglycemic and Lipid-Modulating Effects
The antidiabetic activity of the aqueous seed extract is demonstrated in both normoglycemic and streptozotocin-induced diabetic rats. In normoglycemic rats, the extract at 1,000 milligrams per kilogram reduced blood glucose by 28.77 percent at two hours, comparable to glibenclamide's 31.28 percent reduction. In diabetic rats over 30 days, the extract at 1,000 milligrams per kilogram reduced fasting blood glucose by 49.39 percent, approaching metformin's 53.32 percent reduction. The extract also modulated lipid profile alterations in diabetic rats in a dose-dependent manner, reducing triglycerides, total cholesterol, and low-density lipoprotein while increasing high-density lipoprotein . The mechanism may involve enhanced insulin sensitivity, inhibition of glucose absorption, or direct effects on pancreatic beta cells.
6.3 Cardioprotective Activity: Anti-fibrotic and Anti-inflammatory Effects
The hydroalcoholic extract of Rudraksha demonstrates significant cardioprotective effects in monocrotaline-induced right ventricular failure in rats. Treatment attenuated right ventricular dysfunction by downregulating fibrotic and inflammatory markers including alpha-smooth muscle actin, galectin-3, C-reactive protein, troponin I, connective tissue growth factor, and atrial natriuretic peptide. The extract also reduced oxidative stress induced by neutrophil storms and modulated neurohormonal triggering. Histological studies showed distinct restoration of cardiac morphology. UPLC-QTOF/MS analysis identified 36 chemical constituents belonging to alkaloids, phenolic acids, flavonoids, and glycosides, with in silico docking confirming interactions with disease targets .
6.4 Gastroprotective Activity: Muscarinic Receptor Antagonism and Anti-inflammatory Effects
The gastroprotective activity of leaf extracts is mediated through multiple mechanisms. Methanolic extract containing lupeol and ursolic acid demonstrated significant reduction in ulcer indices in various experimental models. In vitro analysis proved that the extracts act as antagonists of acetylcholine and histamine, suggesting muscarinic receptor and histamine receptor blockade as mechanisms. Molecular docking studies confirmed very good interactions with the M3 muscarinic receptor. Histopathological analysis clearly supported the biochemical findings, with dose-dependent protection of gastric mucosa .
6.5 Antimicrobial Activity: Membrane Disruption and Enzyme Inhibition
The antibacterial activity of Elaeocarpus ganitrus extracts against multidrug-resistant pathogens is attributed to the presence of alkaloids, tannins, phenols, flavonoids, terpenoids, and phytosterols. These compounds disrupt bacterial cell membranes, cause leakage of intracellular contents, and inhibit essential bacterial enzymes. The ethanolic extract demonstrated significant activity against multidrug-resistant Escherichia coli and Staphylococcus aureus isolated from bovine mastitis, with both organisms exhibiting multidrug resistance patterns (MAR indices greater than 0.2) . The antifungal activity against Aspergillus niger, Candida albicans, and other fungal strains is similarly attributed to these bioactive compounds .
6.6 Antioxidant Activity: Free Radical Scavenging and Metal Chelation
The antioxidant activity of Elaeocarpus ganitrus leaves is attributed to its phenolic and flavonoid content. The ethanolic extract demonstrates significant total antioxidant activity, reducing power potential, metal chelating activity, and ABTS scavenging activity. A positive correlation between total phenolic content and antioxidant capacity, and between total flavonoid content and antioxidant activity, confirms that these compounds are the primary contributors to the plant's antioxidant effects . This antioxidant activity underpins many of the plant's protective effects, including its cardioprotective, neuroprotective, and anti-inflammatory activities.
---
7. Traditional and Ethnobotanical Uses
7.1 Hypertension and Cardiovascular Support
Formulation: Seed powder, aqueous extract, or wearing of Rudraksha beads.
Preparation and Use: In Ayurveda, the seeds are powdered and administered orally for hypertension. The aqueous extract is prepared by soaking the powder overnight and is taken in divided doses. Wearing Rudraksha beads is believed to help regulate heart rate and blood pressure through purported bio-electromagnetic properties .
Scientific Validation: Animal studies confirm significant antihypertensive activity of the aqueous seed extract in renal artery-occluded and cadmium chloride-induced hypertensive models. A 2026 clinical investigation of a wearable bio-electromagnetic therapeutic system derived from pulverized seeds demonstrated favorable improvements in ECG, ECHO, blood pressure, and pulse rate in cardiovascular patients receiving standard pharmacotherapy, without adverse reactions .
7.2 Diabetes Mellitus (Madhumeha)
Formulation: Aqueous seed extract, seed powder.
Preparation and Use: The seeds are soaked in water overnight, and the resulting extract is consumed in the morning. Alternatively, seed powder is administered orally. Traditional use for diabetes is documented across Ayurvedic texts .
Scientific Validation: Animal studies demonstrate significant hypoglycemic and antihyperglycemic effects of the aqueous seed extract in both normal and streptozotocin-induced diabetic rats, with efficacy approaching metformin. The extract also improves lipid profiles .
7.3 Anxiety, Depression, and Stress (Chittodvega)
Formulation: Wearing of Rudraksha beads, seed powder.
Preparation and Use: The most common traditional use is wearing Rudraksha beads as a mala or bracelet, believed to calm the mind and reduce stress. Seed powder may also be administered orally. The plant is considered a natural tranquilizer .
Scientific Validation: Traditional use is supported by the plant's reputation and preliminary evidence of anxiolytic and antidepressant activity. The hydroalcoholic extract demonstrates downregulation of neurohormonal and oxidative stress markers in animal models .
7.4 Gastrointestinal Disorders and Ulcers
Formulation: Leaf extract, seed powder.
Preparation and Use: The leaves are prepared as an extract or decoction for stomach ulcers, gastritis, and other gastrointestinal complaints. The plant is reputed to treat a number of stomach issues in Ayurvedic practice .
Scientific Validation: Animal studies confirm significant gastroprotective activity of the methanolic leaf extract, with reduction in ulcer indices and histopathological protection. The extract acts as an antagonist of acetylcholine and histamine, supporting its use for ulcers .
7.5 Epilepsy and Convulsions (Apasmara)
Formulation: Seed powder, extract.
Preparation and Use: The seeds are used traditionally to treat epilepsy and convulsions. The powder is administered orally, often in combination with other herbs .
Scientific Validation: Traditional use is documented in Ayurvedic literature, though specific mechanistic studies are limited. The plant's anticonvulsant activity is attributed to its alkaloid content.
7.6 Asthma and Respiratory Disorders
Formulation: Fruit extract.
Preparation and Use: The fruits are used traditionally for asthma and bronchial conditions. Extracts are prepared and administered orally .
Scientific Validation: Animal studies demonstrate mast-cell stabilizing activity of fruit extracts, substantiating traditional use for bronchial asthma. The extracts inhibit autacoid release from mast cells .
7.7 Regional Ethnomedicinal Applications Summary
India: In Ayurveda, the plant is used extensively for hypertension, diabetes, anxiety, epilepsy, and gastrointestinal disorders. The Rudraksha bead is worn for spiritual and therapeutic purposes. The five-faced bead is particularly associated with cardiac and diabetic benefits .
Nepal and Himalayan Region: The tree is valued for its spiritual significance, and the beads are used in religious practices. Medicinal uses parallel those in India.
Southeast Asia (Indonesia, Thailand, Philippines): The tree is known as Jenitri or Mahae, with local uses for similar conditions. The fruit is sometimes consumed as food.
---
8. Healing Recipes, Teas, Decoctions, and Practical Applications
8.1 Rudraksha Seed Decoction for Hypertension and Cardiovascular Support
Purpose: To support cardiovascular health and manage hypertension.
Preparation and Use: Take 10 grams of dried Rudraksha seed powder. Boil in 500 millilitres of water for 15 minutes. Strain and allow to cool. Drink one cup twice daily. Alternatively, soak 5 grams of seed powder in a glass of water overnight, strain in the morning, and drink on an empty stomach.
Scientific Validation: Animal studies confirm significant antihypertensive activity of the aqueous seed extract in hypertensive models, with blood pressure reductions of up to 30 millimetres of mercury. The 2026 clinical investigation of a wearable bio-electromagnetic system derived from the seeds demonstrated favorable cardiovascular outcomes .
---
8.2 Rudraksha Seed Tea for Blood Sugar Support
Purpose: To support healthy blood sugar levels.
Preparation and Use: Take one teaspoon of dried, powdered Rudraksha seed. Steep in 250 millilitres of hot water for 10 minutes. Strain and drink warm, once or twice daily before meals.
Scientific Validation: The aqueous seed extract demonstrates significant hypoglycemic and antihyperglycemic effects in animal models, with reductions in fasting blood glucose approaching metformin's efficacy. The extract also improves lipid profiles .
---
8.3 Rudraksha Leaf Extract for Gastrointestinal Support
Purpose: To support gastrointestinal health and manage ulcers.
Preparation and Use: Prepare an extract from dried Rudraksha leaves using water or ethanol. Dilute appropriately and consume in small quantities, or obtain a commercially prepared extract. For oral use, consult a qualified practitioner for appropriate dosing.
Scientific Validation: Animal studies confirm the gastroprotective activity of leaf extracts, with reduction in ulcer indices and protection of gastric mucosa. The extract acts as an antagonist of acetylcholine and histamine .
---
8.4 Rudraksha Bead Application (External Use)
Purpose: To harness the purported bio-electromagnetic properties for cardiovascular and general wellness support.
Preparation and Use: Wear Rudraksha beads as a mala around the neck, a bracelet on the wrist, or as a pendant over the precordial area. Clean the beads periodically with mild soap and water. The beads may also be placed in a sachet and applied externally over the chest for cardiovascular support.
Scientific Validation: A 2026 clinical investigation of a wearable bio-electromagnetic quantum therapeutic system derived from pulverized Elaeocarpus ganitrus seed demonstrated favorable improvements in ECG, ECHO, blood pressure, pulse rate, and physiological recovery indices in cardiovascular patients. The system exhibited piezoelectric behavior and dielectric absorptive wave interference, with complete absence of transmembrane penetration, suggesting external non-invasive activity .
---
8.5 Rudraksha Fruit Pulp for Appetite Stimulation
Purpose: To stimulate appetite and support digestive function.
Preparation and Use: The ripe fruit pulp is consumed directly or mixed with honey. Take a small quantity as needed. The seed kernel is applied externally for burns and skin eruptions.
Scientific Validation: Traditional use of the fruit pulp to stimulate appetite is documented. The seed kernel is traditionally applied to burns and areas affected by smallpox eruptions, measles, and fever .
---
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Antihypertensive: Strong evidence from animal studies. Multiple studies demonstrate significant blood pressure reduction in hypertensive models, with copper ions potentially enhancing the effect. A 2026 clinical investigation of a wearable system derived from the seeds showed favorable cardiovascular outcomes .
Antidiabetic: Strong evidence from animal studies. The aqueous seed extract demonstrates significant hypoglycemic and antihyperglycemic effects in normal and diabetic rats, with efficacy approaching metformin. Lipid profile modulation is also documented .
Gastroprotective: Moderate to strong evidence from animal studies. Leaf extracts demonstrate significant reduction in ulcer indices, with mechanistic support from docking studies and in vitro analysis .
Cardioprotective: Moderate evidence from animal studies. The hydroalcoholic extract attenuates right ventricular dysfunction in pulmonary hypertension models, with downregulation of fibrotic and inflammatory markers .
Antimicrobial: Moderate evidence from in vitro studies. Extracts demonstrate activity against multidrug-resistant bacteria and various fungal strains .
Antioxidant: Moderate evidence from in vitro studies. Leaf extracts show significant antioxidant activity correlating with phenolic and flavonoid content .
Immunostimulatory: Preliminary evidence from in vitro and in vivo studies. The alkaloidal fraction of seeds stimulates immune mediators and cell proliferation .
Antiasthmatic: Preliminary evidence from animal studies. Fruit extracts demonstrate mast-cell stabilizing activity .
Anticancer: Preliminary evidence from in silico studies. Phytochemicals interact with STAT3, warranting further investigation .
9.2 Clinical Trial Data
A 2026 pilot clinical investigation evaluated a wearable bio-electromagnetic quantum therapeutic system derived from pulverized Elaeocarpus ganitrus seed in twelve cardiovascular patients receiving standard pharmacotherapy. Outcomes included ECG, echocardiography, blood pressure, pulse rate, and retrieval rate toward normal physiological status. Results indicated favorable improvements in all measured parameters following adjunctive administration, without evidence of local irritation or adverse reactions. The study authors noted that larger randomized controlled trials are warranted to validate therapeutic efficacy and elucidate mechanisms . No other human clinical trials have been conducted on Elaeocarpus ganitrus for any indication.
9.3 Safety and Toxicology Data
Acute oral toxicity studies demonstrate that the aqueous seed extract is nontoxic, with no mortality observed up to 5 grams per kilogram in mice, indicating an LD50 greater than 5 grams per kilogram . This exceptionally high safety margin suggests low acute toxicity. Traditional use spanning centuries without reported serious adverse effects supports the plant's safety profile. However, comprehensive chronic toxicity, genotoxicity, and reproductive toxicity studies are lacking.
---
10. Safety and Toxicology
10.1 Toxicity Profile
Acute Toxicity: Animal studies indicate very low acute toxicity. No mortality was observed at doses up to 5 grams per kilogram in mice, indicating an LD50 greater than 5 grams per kilogram .
Clinical Safety: The plant has a long history of traditional use without reported serious adverse effects. The seeds are consumed orally in traditional preparations, and the beads are worn externally without known toxicity.
Reproductive and Developmental Toxicity: No data is available. Use during pregnancy and lactation should be avoided without professional guidance.
Other Considerations: The fruit pulp is edible but astringent. The seed kernel is applied externally and should not be ingested in large quantities. Individuals with known hypersensitivity to the Elaeocarpaceae family should avoid use.
10.2 Contraindications and Precautions
Pregnancy and Lactation: Avoid oral use without professional supervision, as safety data is lacking.
Children: No safety data is available. Use should be avoided in children without professional guidance.
Hypotension: The plant may lower blood pressure. Individuals with low blood pressure should use with caution.
Surgery: Due to potential effects on blood pressure and blood sugar, the plant should be discontinued 2 weeks prior to scheduled surgery.
Known Hypersensitivity: Individuals with known hypersensitivity to Elaeocarpus ganitrus or the Elaeocarpaceae family should avoid use.
10.3 Potential Drug Interactions
Antihypertensive Medications: The mechanism involves additive blood pressure-lowering effect. The clinical significance is the risk of excessive hypotension. Monitor blood pressure if used with antihypertensive medications .
Antidiabetic Medications (Metformin, Sulphonylureas, Insulin): The mechanism involves additive glucose-lowering effect. The clinical significance is the risk of hypoglycaemia. Monitor blood glucose if used with antidiabetic medications .
Anticoagulants and Antiplatelet Drugs: The mechanism involves potential inhibition of platelet aggregation. The clinical significance is increased bleeding risk. Monitor bleeding parameters if used with anticoagulants.
CNS Depressants: The plant may potentiate the effects of sedatives and anxiolytics. Use with caution.
---
11. Quality Control Parameters
11.1 Marker Compounds for Standardisation
Key compounds suitable as quality markers include rudrakine, lupeol, ursolic acid, and total alkaloid content. These compounds provide a foundation for standardising extracts and ensuring consistent quality and biological activity. The presence of these markers can be verified using HPTLC and HPLC methods .
11.2 Recommended Analytical Methods
High-performance thin-layer chromatography (HPTLC) is recommended for fingerprinting and quantification of lupeol and ursolic acid. High-performance liquid chromatography (HPLC) with diode array detection (DAD) or liquid chromatography with tandem mass spectrometry (LC-MS/MS) is recommended for quantification of alkaloids and flavonoids. UPLC-QTOF/MS can be used for comprehensive phytochemical profiling, as demonstrated in recent studies identifying 36 chemical constituents . Total phenolic content (TPC) assay using the Folin-Ciocalteu method is recommended for determining overall phenolic content.
11.3 Suggested Specifications
For the seed extract, the total alkaloid content should be specified. For the leaf extract, the lupeol and ursolic acid content should be standardised. Heavy metal analysis and microbial load testing should comply with regulatory requirements for herbal products. The endocarp (bead) should be authenticated based on morphological characteristics, including the number of mukhas (faces).
---
12. Cultivation and Sustainability
12.1 Growth Requirements
Climate: The tree thrives in tropical and subtropical climates with distinct wet and dry seasons.
Habitat: It prefers humid, moist environments and is often found along riverbanks and in evergreen forests.
Altitude: It grows from sea level to approximately 2,000 metres elevation.
Soil: It prefers deep, fertile, well-drained soils but is adaptable to various soil types.
Propagation: It is propagated from seeds, which require scarification or soaking to germinate. Seedlings are slow-growing initially but establish well. The tree can also be propagated from cuttings.
12.2 Sustainable Harvesting
Plant parts harvested: Seeds (endocarp), leaves, and bark are harvested for medicinal purposes. The beads are collected from ripe fruits.
Harvesting method: Fruits are collected when ripe and the endocarp is extracted. Leaves can be harvested without harming the tree. Bark should be harvested sustainably by removing small sections.
Season: Fruits ripen from August to October in the Indian subcontinent. Leaves can be harvested year-round.
Caution: Source from cultivated plants or sustainably managed wild populations to avoid overharvesting. The Rudraksha bead trade has raised concerns about sustainability in some regions.
12.3 Conservation Status
The species is not currently listed as threatened. It is widely cultivated and has stable populations across its native range. However, overharvesting for the bead trade has raised concerns in some areas, and cultivation is being promoted to meet demand sustainably.
---
13. Cultivar and Varietal Comparison
Elaeocarpus ganitrus versus Elaeocarpus sylvestris
Taxonomy: Both belong to the genus Elaeocarpus in the Elaeocarpaceae family. Elaeocarpus ganitrus is native to the Indian subcontinent and Southeast Asia, while Elaeocarpus sylvestris is native to East Asia.
Leaves: Elaeocarpus ganitrus leaves are oblong to lanceolate with serrated margins and turn red before falling. Elaeocarpus sylvestris leaves are similar but generally smaller and more leathery.
Fruits: Elaeocarpus ganitrus fruits are blue to bluish-purple drupes with a deeply sculptured endocarp, while Elaeocarpus sylvestris fruits are also blue but smaller and with a less sculptured endocarp.
Traditional medicinal uses: Both species are used in traditional medicine. Elaeocarpus ganitrus is particularly valued for its Rudraksha beads and for hypertension, diabetes, and anxiety. Elaeocarpus sylvestris is used for dysentery and inflammation.
Toxicity: Both species appear to have low toxicity based on traditional use and limited animal studies.
---
14. Research Gaps and Future Directions
14.1 Critical Research Gaps
Human Clinical Trials: Comprehensive clinical trials are lacking for most therapeutic claims, including antidiabetic, antihypertensive, gastroprotective, and cardioprotective effects. High-quality randomized controlled trials are needed to establish efficacy and safety in humans.
Pharmacokinetics: No data exists on the absorption, metabolism, and bioavailability of key compounds, including alkaloids and flavonoids.
Mechanistic Studies: Further elucidation of molecular pathways is needed for antidiabetic, antihypertensive, and cardioprotective activities.
Standardised Formulations: There is a need for stable, standardised phytopharmaceutical preparations with consistent quality and efficacy.
Long-term Safety: Chronic toxicity, genotoxicity, and reproductive toxicity studies are lacking.
Bio-electromagnetic Research: The purported bio-electromagnetic properties of Rudraksha beads warrant rigorous scientific investigation to validate or refute traditional claims.
Comparative Studies: More comprehensive studies are needed to compare the pharmacological profiles of different parts (seed, leaf, bark) and their specific applications.
14.2 Future Research Priorities
Antidiabetic Drug Development: The promising preclinical data warrants further investigation through clinical trials to validate the antidiabetic effects observed in animal models.
Cardiovascular Applications: Larger randomized controlled trials are needed to validate the promising findings from the 2026 wearable system study.
Gastroprotective Applications: Clinical trials are needed to establish efficacy for peptic ulcer disease.
Bio-electromagnetic Mechanisms: Rigorous studies are needed to investigate the purported bio-electromagnetic and piezoelectric properties of Rudraksha beads.
Anticancer Studies: Further investigation of the in silico STAT3 interactions through in vitro and in vivo studies.
---
15. Commercial Applications
15.1 Spiritual and Wellness Products
Rudraksha beads are a major commercial product, sold globally as malas, bracelets, and pendants. The beads are valued for their spiritual significance and purported therapeutic benefits. The market encompasses a wide range of bead types based on the number of mukhas.
15.2 Pharmaceutical and Nutraceutical Applications
The plant has potential for development as a source of antihypertensive, antidiabetic, and gastroprotective compounds. Standardised extracts can be developed as nutraceutical ingredients and dietary supplements. The promising preclinical data warrants further development through clinical trials.
15.3 Wearable Therapeutic Systems
The 2026 development of a wearable bio-electromagnetic quantum therapeutic system derived from pulverized seeds represents a novel commercial application for cardiovascular support. The system demonstrated favorable preliminary clinical outcomes and an excellent safety profile, warranting further development .
15.4 Cosmetic and Personal Care Products
The antioxidant and antimicrobial properties of the leaf extract suggest potential applications in skincare formulations. The extract can be incorporated into anti-aging creams and skin-soothing products.
---
16. Related Plants for Further Study
Elaeocarpus sylvestris: A closely related species with documented antimicrobial and anti-inflammatory activities, warranting comparative study.
Elaeocarpus angustifolius: Native to Australia, with similar blue fruits and potential medicinal properties.
Elaeocarpus serratus: Ceylon Olive, used traditionally for diarrhoea and rheumatism.
Elaeocarpus tuberculatus: A South Indian species with bead-producing fruits.
Terminalia chebula (Haritaki): While not in the Elaeocarpaceae family, this plant is often used in Ayurvedic formulations for gastrointestinal and cardiovascular support, complementary to Elaeocarpus ganitrus.
Withania somnifera (Ashwagandha): Another Ayurvedic herb with adaptogenic and anxiolytic properties, often combined with Rudraksha for stress management.
---
17. Reference Literature
Primary Research
Kalaiselvi L, Ramesh S, Jayaraman M. Antibacterial activity of Elaeocarpus ganitrus and Acacia nilotica extracts against multidrug resistant Escherichia coli and Staphylococcus aureus. Indian Journal of Veterinary and Animal Sciences Research. 2025;54(6):87-100. This study demonstrates the antibacterial activity of ethanolic extracts against multidrug-resistant mastitis pathogens, with phytochemical analysis confirming the presence of alkaloids, tannins, phenols, flavonoids, terpenoids, phytosterols, and steroids .
Hule AK, et al. An evaluation of the antidiabetic effects of Elaeocarpus ganitrus in experimental animals. Indian J Pharmacol. 2011;43(1):56-59. This study demonstrates significant hypoglycemic and antihyperglycemic effects of the aqueous seed extract in normal and streptozotocin-induced diabetic rats, with lipid profile modulation and no toxicity up to 5 grams per kilogram .
Sharma AK, et al. HPTLC studies, in silico docking studies, and pharmacological evaluation of Elaeocarpus ganitrus as a gastroprotective agent. Cent Nerv Syst Agents Med Chem. 2023;23(1):13-31. This study demonstrates gastroprotective activity of leaf extracts, with HPTLC identification of lupeol and ursolic acid, and molecular docking confirming interaction with muscarinic M3 receptors .
Rudraksha attenuates right ventricular dysfunction in pulmonary hypertension induced Wistar rats. ScienceDirect. 2025. This study demonstrates cardioprotective effects of hydroalcoholic extract in right ventricular failure, with downregulation of fibrotic and inflammatory markers and identification of 36 chemical constituents .
Roy S, et al. Development and clinical evaluation of a wearable bio-electromagnetic quantum therapeutic system from Elaeocarpus ganitrus for cardiovascular supportive therapy. Adolescência e Saúde. 2026;21(5s):209-223. This pilot clinical investigation demonstrates favorable cardiovascular outcomes with a wearable system derived from pulverized seeds, with excellent safety profile .
Does copper enhance the antihypertensive effect of Elaeocarpus ganitrus in experimentally induced hypertensive rats? Europe PMC. 2014. This study demonstrates significant antihypertensive activity of seed extracts in cadmium chloride-induced hypertensive rats, with copper ions potentially enhancing the effect .
Sudradjat SE, Timotius KH. Pharmacological properties and phytochemical components of Elaeocarpus: A comparative study. Phytomedicine Plus. 2022;2:100365. This comprehensive review compiles the pharmacological properties and bioactive compounds of Elaeocarpus species, identifying alkaloids, phenolics, flavonoids, and cucurbitacins as core bioactive compounds .
Key Monographs and Floras
Singh B, et al. Phytochemical and biological aspects of Rudraksha, the stony endocarp of Elaeocarpus ganitrus (Roxb.): a review. 2015. This review summarizes the ethnopharmacology, chemical composition, pharmacology, and toxicology of Elaeocarpus ganitrus .
Bansal S, et al. Botanical, phytochemical, and ethnomedical aspects of Elaeocarpus ganitrus. Current Functional Foods. 2025;3(2):E230524230245. This review examines the scientific data on the compositional and biochemical properties, in vivo and in vitro activities, and clinical analysis of Rudraksha .
Garurav K, Loganathan K, Bhaskara RKV. A review on medicinal properties of Elaeocarpus ganitrus Roxb.ex G. Don. (Elaeocarpaceae). Research Journal of Pharmacy and Technology. 2014;7(10):1184-1186. This review summarizes the medicinal properties of the plant, including antimicrobial, anti-inflammatory, antihypertensive, anxiolytic, antidepressant, and antidiabetic activities .
---
18. Disclaimer
Elaeocarpus ganitrus is generally considered safe based on traditional use and acute toxicity studies demonstrating no mortality up to 5 grams per kilogram in animals. However, concentrated extracts should be used with caution.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Pregnant or nursing women should consult a healthcare professional before use.
Individuals on medication, especially antihypertensives, antidiabetics, or anticoagulants, should consult a qualified healthcare practitioner before use.
Do not discontinue prescribed medications without consulting your doctor.
Proper identification is crucial to avoid confusion with other Elaeocarpus species.
Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.
Comments